Techniques for Minimally Invasive Rejuvenation of the Periorbital Region CME/CE

Author Information and Disclosures

Release Date: May 30, 2008; Valid for credit through May 30, 2009

Credits Available
Physicians - maximum of 1.25 AMA PRA Category 1 Credit(s)™ for physicians;
Nurses - 1.25 nursing contact hours (None of these credits is in the area of pharmacology)

To participate in this internet activity: (1) review the target audience, learning objectives, and author disclosures; (2) study the education content; (3) take the post-test and/or complete the evaluation; (4) view/print certificate View details.

Contents of This CME/CE Activity

  • Techniques for Minimally Invasive Rejuvenation of the Periorbital RegionHema Sundaram, MD, FAAD

    • Editor's note: In the cases presented in this program, one product line of nonanimal stabilized hyaluronic acid (NASHA) fillers is used. There have been no head-to-head clinical trials comparing NASHAs, and the use of particular products in these cases should be viewed as a clinical choice and not as a representation of product attributes that have been demonstrated in clinical trials or as an endorsement of particular products by Medscape. These cases discuss off-label uses of NASHAs and botulinum toxin A.

Legal Disclaimer

The material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.

Copyright © 2008 Medscape.
Medicis
Learning Objectives

Upon completion of this activity, participants will be able to:

  1. Review the causative factors and anatomic changes implicated in aging of the periorbital region
  2. Assess a patient's candidacy for the use of particular rejuvenation strategies
  3. Recognize the goals of corrective procedures and how to appropriately manage patient expectations
  4. Review proper injection techniques for dermal fillers to maximize aesthetic outcomes and minimize adverse effects
Authors and Disclosures

Hema Sundaram MD, FAAD
Disclosure: Hema Sundaram MD, FAAD, has disclosed that she has received grants for clinical research and has served as an advisor or consultant for Medicis. She has also disclosed that she has served as a speaker for Medicis, Allergan, Reliant, and ColoreScience.


Kristin M. Richardson
Disclosure: Kristin M. Richardson has disclosed no relevant financial relationships.


Lynne K. Schneider, PhD
Disclosure: Lynne K. Schneider, PhD, has disclosed no relevant financial relationships.
 
Medscape
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Medscape, LLC designates this educational activity for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Contact This Provider

 
This Activity is sponsored by Medscape Continuing Education Provider Unit.

Medscape is an approved provider of continuing nursing education by the New York State Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation.

Awarded 1.25 contact hour(s) of continuing nursing education for RNs and APNs; none of these credits is in the area of pharmacology.

Provider Number: 6FDKKC-PRV-05

Contact This Provider

All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.